C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/238, 260/305
C07D 403/06 (2006.01) A61K 31/415 (2006.01) C07D 209/88 (2006.01) C07D 521/00 (2006.01)
Patent
CA 1252793
A B S T R A C T Heterocyclic Compounds The invention relates to compounds of formula (I). Image (I) wherein R1 represents a hydrogen atom or a C1-10 alkyl, C3-7 cycloalkyl, C3-6 alkenyl, phenyl or phenyl-C1-3alkyl group, and one of the groups represented by R2, R3 and R4 is a hydrogen atom or a C1-6 alkyl, C3-7 cycloalkyl, C2-6 alkenyl or phenyl-C1-3alkyl group and each of the other two groups, which may be the same or different, represents a hydrogen atom or a C1-6 alkyl group; and physiologically acceptable salts and solvates, e.g. hydrates, thereof. The compounds are potent selective antagonists at "neuronal" 5-hydroxytryptamine receptors and are useful in the treatment of migraine and psychotic disorders such as schizophrenia.
472888
Bell James A.
Coates Ian H.
Ewan George B.
Humber David C.
Glaxo Group Limited
Riches Mckenzie & Herbert Llp
LandOfFree
1,2,3,9-tetrahydro-3-¬(imidazol-1-yl) methyl|... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1,2,3,9-tetrahydro-3-¬(imidazol-1-yl) methyl|..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2,3,9-tetrahydro-3-¬(imidazol-1-yl) methyl|... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1327653